An anticancer drug developed by researchers from the University of Florida College of Pharmacy has become the first drug of its kind allowed to proceed to clinical trial by the U.S. Food and Drug Administration.
Ariana Brice-Tutt's final defense was presented March 10.
UF pharmacy researchers have found a potential new way of targeting a population of immune-suppressive T cells that could possibly benefit a large population of cancer patients, including those who will not respond to other immunotherapies.
A tissue-chip experiment led by Siobhan Malany, Ph.D., an associate professor of pharmacodynamics in the University of Florida College of Pharmacy, returned to Earth Jan. 13.
The grant will help to develop novel senolytic agents and identify molecular targets that are important for survival of senescent cells.
The study led by Siobhan Malany, Ph.D., will help scientists understand microgravity effects on human muscle cells and could aid the development of new therapies for age-related muscle loss on Earth.
Guillaume de Lartigue, Ph.D., an assistant professor of pharmacodynamics, is a multiple principal investigator of a National Institute of Diabetes and Digestive and Kidney Diseases R01 grant, which began July 1, 2020. Dr. Guillaume de Lartigue The grant titled “Consequence and mechanism of diet-driven vagal remodeling on gut-brain feeding behavior” will…
Daohong Zhou, M.D., a professor of pharmacodynamics, has received multiple recent grants, including a multiple principal investigator R01 from the National Cancer Institute, alongside his longtime collaborator Guangrong Zheng, Ph.D., an associate professor of medicinal chemistry Dr. Daohong Zhou The grant titled “Inhibition of Bcl-xL by Targeted Degradation” will carry…
The University of Florida College of Pharmacy awarded the three prestigious fellowships at a virtual award ceremony Oct. 13.
Guillaume de Lartigue, Ph.D., an assistant professor of pharmacodynamics, and Alan Moreira de Araujo, Ph.D., a postdoctoral associate, were invited to write an article in one of the leading journals in their field, Nature Reviews Gastroenterology & Hepatology. The article titled, “Non-canonical cholinergic anti-inflammatory pathway in IBD,”…